Literature DB >> 22039322

Inhibition of high-mobility group box 1 expression by siRNA in rat hepatic stellate cells.

Wen-Song Ge1, Jian-Xin Wu, Jian-Gao Fan, Yao-Jun Wang, Ying-Wei Chen.   

Abstract

AIM: To explore the role of high-mobility group box 1 (HMGB1) protein during liver fibrogenesis and investigate the functional effects of HMGB1 gene silencing in hepatic stellate cells (HSCs) using siRNA.
METHODS: Hepatic fibrosis in rats was induced throu-gh serial subcutaneous injections of dimethylnitrosamine, and expression of HMGB1 was detected by immunohistochemistry. HMGB1 siRNAs were developed and transiently transfected into HSC-T6 cells using Lipofectamine 2000. HMGB1 expression was evaluated by real-time polymerase chain reaction (PCR) and Western blotting analysis. Expression of α-smooth muscle actin (α-SMA) and collagen types I and III was evaluated by real-time PCR. Cell proliferation and the cell cycle were determined using the methyl thiazolyl tetrazolium method. Finally, collagen content in HSC supernatant was evaluated by an enzyme-linked immunosorbent assay.
RESULTS: The results showed that HMGB1 was upregulated during liver fibrosis and that its expression was closely correlated with the deposition of collagen. siRNA molecules were successfully transfected into HSCs and induced inhibition of HMGB1 expression in a time-dependent manner. Moreover, HMGB1 siRNA treatment inhibited synthesis of α-SMA and collagen types I and III in transfected HSCs.
CONCLUSION: This study suggests a significant fun-ctional role for HMGB1 in the development of liver fibrosis. It also demonstrates that downregulation of HMGB1 expression might be a potential strategy to treat liver fibrosis.

Entities:  

Keywords:  Hepatic fibrosis; Hepatic stellate cells; High-mobility group box 1; RNA interference

Mesh:

Substances:

Year:  2011        PMID: 22039322      PMCID: PMC3203359          DOI: 10.3748/wjg.v17.i36.4090

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

1.  Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion.

Authors:  Tiziana Bonaldi; Fabio Talamo; Paola Scaffidi; Denise Ferrera; Annalisa Porto; Angela Bachi; Anna Rubartelli; Alessandra Agresti; Marco E Bianchi
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

2.  HMG-1 as a late mediator of endotoxin lethality in mice.

Authors:  H Wang; O Bloom; M Zhang; J M Vishnubhakat; M Ombrellino; J Che; A Frazier; H Yang; S Ivanova; L Borovikova; K R Manogue; E Faist; E Abraham; J Andersson; U Andersson; P E Molina; N N Abumrad; A Sama; K J Tracey
Journal:  Science       Date:  1999-07-09       Impact factor: 47.728

3.  High-mobility group box 1 exacerbates concanavalin A-induced hepatic injury in mice.

Authors:  Quan Gong; Hui Zhang; Jun-hua Li; Li-hua Duan; Shan Zhong; Xiao-ling Kong; Fang Zheng; Zheng Tan; Ping Xiong; Gang Chen; Min Fang; Fei-li Gong
Journal:  J Mol Med (Berl)       Date:  2010-09-17       Impact factor: 4.599

4.  The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway.

Authors:  Stefania Gardella; Cristina Andrei; Denise Ferrera; Lavinia V Lotti; Maria R Torrisi; Marco E Bianchi; Anna Rubartelli
Journal:  EMBO Rep       Date:  2002-09-13       Impact factor: 8.807

5.  IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism.

Authors:  Beatriz Rendon-Mitchell; Mahendar Ochani; Jianhua Li; Jialian Han; Hong Wang; Huan Yang; Seenu Susarla; Christopher Czura; Robert A Mitchell; Guoqian Chen; Andrew E Sama; Kevin J Tracey; Haichao Wang
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

6.  The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system.

Authors:  O Hori; J Brett; T Slattery; R Cao; J Zhang; J X Chen; M Nagashima; E R Lundh; S Vijay; D Nitecki
Journal:  J Biol Chem       Date:  1995-10-27       Impact factor: 5.157

7.  Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein.

Authors:  Jong Sung Park; Daiva Svetkauskaite; Qianbin He; Jae-Yeol Kim; Derek Strassheim; Akitoshi Ishizaka; Edward Abraham
Journal:  J Biol Chem       Date:  2003-12-04       Impact factor: 5.157

8.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation.

Authors:  Paola Scaffidi; Tom Misteli; Marco E Bianchi
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

9.  High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes.

Authors:  U Andersson; H Wang; K Palmblad; A C Aveberger; O Bloom; H Erlandsson-Harris; A Janson; R Kokkola; M Zhang; H Yang; K J Tracey
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

10.  Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation.

Authors:  Roberta Palumbo; Maurilio Sampaolesi; Francesco De Marchis; Rossana Tonlorenzi; Sara Colombetti; Anna Mondino; Giulio Cossu; Marco E Bianchi
Journal:  J Cell Biol       Date:  2004-01-26       Impact factor: 10.539

View more
  13 in total

1.  Artemisia annua Leaf Extract Attenuates Hepatic Steatosis and Inflammation in High-Fat Diet-Fed Mice.

Authors:  Kyung Eun Kim; Keon-Hee Ko; Rok Won Heo; Chin-ok Yi; Hyun Joo Shin; Jun Young Kim; Jae-Ho Park; Sanghae Nam; Hwajin Kim; Gu Seob Roh
Journal:  J Med Food       Date:  2016-01-07       Impact factor: 2.786

Review 2.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

Review 3.  Emerging role of high-mobility group box 1 (HMGB1) in liver diseases.

Authors:  Ruochan Chen; Wen Hou; Qiuhong Zhang; Rui Kang; Xue-Gong Fan; Daolin Tang
Journal:  Mol Med       Date:  2013-11-08       Impact factor: 6.354

4.  Carnosic Acid Alleviates BDL-Induced Liver Fibrosis through miR-29b-3p-Mediated Inhibition of the High-Mobility Group Box 1/Toll-Like Receptor 4 Signaling Pathway in Rats.

Authors:  Shuai Zhang; Zhecheng Wang; Jie Zhu; Ting Xu; Yan Zhao; Huanyu Zhao; Fan Tang; Zhenlu Li; Junjun Zhou; Dongyan Gao; Xiaofeng Tian; Jihong Yao
Journal:  Front Pharmacol       Date:  2018-01-19       Impact factor: 5.810

5.  Ameliorative Effects of Nilotinib on CCl4 Induced Liver Fibrosis Via Attenuation of RAGE/HMGB1 Gene Expression and Oxidative Stress in Rat.

Authors:  Vahid Khanjarsim; Jamshid Karimi; Iraj Khodadadi; Adel Mohammadalipour; Mohammad Taghi Goodarzi; Ghasem Solgi; Mohammad Hashemnia
Journal:  Chonnam Med J       Date:  2017-05-25

Review 6.  Innate Immunity and Biomaterials at the Nexus: Friends or Foes.

Authors:  Susan N Christo; Kerrilyn R Diener; Akash Bachhuka; Krasimir Vasilev; John D Hayball
Journal:  Biomed Res Int       Date:  2015-07-12       Impact factor: 3.411

Review 7.  Emerging role of HMGB1 in fibrotic diseases.

Authors:  Liu-Cheng Li; Jian Gao; Jun Li
Journal:  J Cell Mol Med       Date:  2014-10-06       Impact factor: 5.310

8.  Suberoylanilide hydroxamic acid suppresses hepatic stellate cells activation by HMGB1 dependent reduction of NF-κB1.

Authors:  Wenwen Wang; Min Yan; Qiuhong Ji; Jinbiao Lu; Yuhua Ji; Juling Ji
Journal:  PeerJ       Date:  2015-11-03       Impact factor: 2.984

Review 9.  High-Mobility Group Box-1 and Liver Disease.

Authors:  Harriet Gaskell; Xiaodong Ge; Natalia Nieto
Journal:  Hepatol Commun       Date:  2018-09-07

Review 10.  The interplay of DAMPs, TLR4, and proinflammatory cytokines in pulmonary fibrosis.

Authors:  Siavash Bolourani; Max Brenner; Ping Wang
Journal:  J Mol Med (Berl)       Date:  2021-07-13       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.